(+)-(2S)-2-((4,6-dimethylpyrimidin-2-yl)oxy)-3-methoxy-3,3-diphenylpropanoic acid,
ambrisentan,
BSF 208075,
BSF-208075,
BSF208075,
Letairis,
LU 208075,
LU-208075,
LU208075,
Ambrisentan,
177036-94-1,
Letairis,
Volibris,
BSF 208075,
(S)-2-(4,6-Dimethylpyrimidin-2-yloxy)-3-methoxy-3,3-diphenylpropanoic acid,
UNII-HW6NV07QEC,
LU-208075,
HW6NV07QEC,
LU 208075,
CHEMBL1111,
(S)-2-((4,6-Dimethylpyrimidin-2-yl)oxy)-3-methoxy-3,3-diphenylpropanoic acid,
BSF-208075,
(2S)-2-(4,6-dimethylpyrimidin-2-yl)oxy-3-methoxy-3,3-diphenylpropanoic acid,
DSSTox_CID_26282,
DSSTox_RID_81508,
DSSTox_GSID_46282,
LU208075,
(s)-2-[(4,6-dimethylpyrimidin-2-yl)oxy]-3-methoxy-3,3-diphenylpropionic acid,
CAS-177036-94-1,
Ambrisentan [INN:BAN:JAN],
(+-)-(2S)-2-((4,6-Dimethylpyrimidin-2-yl)oxy)-3-methoxy-3,3-diphenylpropanoic acid,
BSF 208075;AMBRISENTAN,
NCGC00160662-01,
Letairis (TN),
Volibris (TN),
AK-38379,
AC1OCFHZ,
PubChem18318,
Ambrisentan (JAN/INN),
SCHEMBL3679,
MLS006010218,
GTPL3951,
DTXSID4046282,
CTK8B8152,
CHEBI:135949,
OUJTZYPIHDYQMC-LJQANCHMSA-N,
ZINC538627,
KS-00000FU3,
Tox21_111967,
ANW-59416,
BDBM50146710,
CA0131,
FD7219,
MFCD08672619,
s2097,
AKOS015994540,
Tox21_111967_1,
AC-9015,
CS-0447,
DB06403,
DE-0223,
SB17358,
NCGC00160662-02,
NCGC00346730-01,
AJ-23403,
BC224510,
Benzenepropanoic acid, alpha-[(4,6-dimethyl-2-pyrimidinyl)oxy]-beta-methoxy-beta-phenyl-, (alphaS)-,
HY-13209,
SMR004701307,
AB0009811,
AB2000501,
AX8118907,
TC-148161,
FT-0650339,
SW219060-1,
LU-208075,BSF-208075,
D07077,
K-5435,
AB01566890_01,
A812234,
J-519579,
UNII-7B43003091 component OUJTZYPIHDYQMC-LJQANCHMSA-N,
(?S)-?-[(4,6-Dimethyl-2-pyrimidinyl)oxy]-?-methoxy-?-phenylbenzenepropanoic acid,
(2S)-2-(4,6-dimethylpyrimidin-2-yl)oxy-3-methoxy-3,3-di(phenyl)propanoic acid,
(2S)-2-(4,6-dimethylpyrimidin-2-yl)oxy-3-methoxy-3,3-diphenyl-propanoic acid,
(2S)-2-[(4,6-dimethyl-2-pyrimidinyl)oxy]-3-methoxy-3,3-diphenylpropanoic acid,
(2S)-2-[(4,6-dimethylpyrimidin-2-yl)oxy]-3-methoxy- 3,3-diphenylpropanoic acid,
(S)-2-(4,6-Dimethyl-pyrimidin-2-yloxy)-3-methoxy-3,3-diphenyl-propionic acid,
null,
Ambrisentan [INN],
D0X5ZI,
Gilead brand of ambrisentan,
cc-160,
BSF208075,
C22H22N2O4,
Ambrisentan, 98% - 25MG 25mg,
C22-H22-N2-O4,
ACN-030051,
CID6918493,
CS-O-00462,
A2966,
B2075,
A11291,
C467894,
2-(4,6-dimethylpyrimidin-2-yl)oxy-3-methoxy-3,3-diphenyl-propanoic acid,
2-(4,6-dimethylpyrimidin-2-yl)oxy-3-methoxy-3,3-diphenylpropanoic acid,
2-[(4,6-dimethylpyrimidin-2-yl)oxy]-3-methoxy-3,3-diphenylpropanoic acid,
(+)-(2S)-2-((4,6-dimethylpyrimidin-2-yl)oxy)-3-methoxy-3,3-diphenylpropanoic acid,
(+)-(2s)-2-[(4,6-dimethylpyrimidin-2-yl)oxy]-3-methoxy-3,3-diphenylpropanoic acid,
Benzenepropanoic acid, .alpha.-[(4,6-dimethyl-2-pyrimidinyl)oxy]-.beta.-methoxy-.beta.-phe,
(alpha S)-alpha-[(4,6-Dimethyl-2-pyrimidinyl)oxy]-beta-methoxy-beta-phenylbenzenepropanoic acid,